Physician profile
Constantine E Phiripes
NPI 1063483121
$1,230.38
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,020 · 2020: $210.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $265.50 | 2019-2020 | |
| Pfizer INC. | $168.51 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $153.98 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $110.65 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.25 | 2019-2020 | |
| Glaxosmithkline, LLC. | $68.03 | 2019-2020 | |
| Novo Nordisk INC | $56.78 | 2019 | |
| Amgen INC. | $49.23 | 2019-2020 | |
| Sanofi Pasteur INC. | $42.56 | 2019-2020 | |
| Radius Health, INC. | $41.34 | 2019 | |
| Allergan, INC. | $38.51 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $37.90 | 2019 | |
| Lilly USA, LLC | $28.18 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.52 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.48 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $12.43 | 2019 | |
| Medtronic USA, INC. | $11.38 | 2019 | |
| Therapeuticsmd, INC. | $11.15 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constantine Phiripes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.